Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 116.22B | 115.61B | 122.85B | 118.76B | 89.71B | 88.68B |
Gross Profit | 36.92B | 34.91B | 36.41B | 34.96B | 36.21B | 41.77B |
EBITDA | 14.70B | 11.91B | 12.21B | 10.24B | 11.68B | 15.97B |
Net Income | 3.24B | 1.62B | 1.46B | 219.00M | 1.74B | 4.93B |
Balance Sheet | ||||||
Total Assets | 165.10B | 168.25B | 161.10B | 147.46B | 131.77B | 123.19B |
Cash, Cash Equivalents and Short-Term Investments | 18.51B | 20.14B | 26.18B | 16.12B | 14.74B | 16.58B |
Total Debt | 27.75B | 24.63B | 28.79B | 27.95B | 19.28B | 10.34B |
Total Liabilities | 67.11B | 69.38B | 68.56B | 57.94B | 46.34B | 39.85B |
Stockholders Equity | 94.63B | 95.62B | 89.40B | 86.88B | 82.84B | 80.85B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -6.21B | 15.32B | -4.86B | -5.10B | -566.00M |
Operating Cash Flow | 0.00 | 10.01B | 28.33B | 6.91B | 8.67B | 14.18B |
Investing Cash Flow | 0.00 | -9.65B | -25.06B | -15.63B | -17.18B | -19.49B |
Financing Cash Flow | 0.00 | -1.02B | -2.63B | 10.10B | 6.68B | 3.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | ¥37.81B | 11.09 | 1.81% | 1.39% | ― | ||
66 Neutral | $17.24B | 17.99 | 5.60% | 3.67% | 6.63% | 11.55% | |
― | €425.00M | 8.46 | 8.21% | ― | ― | ― | |
― | €488.12M | 11.37 | 6.08% | ― | ― | ― | |
81 Outperform | ¥58.45B | 5.27 | 2.67% | 1.12% | -3.79% | ||
73 Outperform | ¥79.46B | 10.83 | 1.42% | -2.76% | 17.20% | ||
71 Outperform | ¥18.00B | 7.29 | 2.15% | 5.66% | ― |